Magnetic resonance (MR) imaging is rapidly gaining acceptance as an accurat
e, reproducible, noninvasive method for optimal assessment of structural an
d functional parameters in patients with valvular heart disease. The severi
ty of valvular regurgitation can be evaluated with cine gradient-echo MR im
aging, which allows measurement of the area of the signal void correspondin
g to the abnormal flow jet. Alternatively, this modality can be used to obt
ain ventricular volumetric measurements and calculate the regurgitant fract
ion, or velocity-encoded cine (VEC) MR imaging can be used to quantify regu
rgitant blood flow. The severity of valvular stenosis can be determined by
evaluating the flow jet and associated findings with either modality or by
using VEC MR imaging to calculate the transvalvular pressure gradient and v
alve area. Dynamic MR imaging allows accurate assessment of ventricular fun
ction and comprehensive evaluation of pathophysiologic changes. In addition
, good interstudy reproducibility suggests a role for VEC NIR imaging in as
sessing the effects of therapeutic intervention and monitoring regurgitant
fraction, thereby helping in surgical planning and the prevention of ventri
cular dysfunction. With greater cost-effectiveness and the increasing avail
ability of new hardware and more advanced techniques, MR imaging will becom
e a routine procedure in valvular heart disease.